The timing of influenza vaccination for older adults (65 years and older).

TitleThe timing of influenza vaccination for older adults (65 years and older).
Publication TypeJournal Article
Year of Publication2009
AuthorsLee BY, H Y Tai J, Bailey RR, Smith KJ
JournalVaccine
Volume27
Issue50
Pagination7110-5
Date Published2009 Nov 23
ISSN1873-2518
KeywordsAged, Computer Simulation, Cost-Benefit Analysis, Health Care Costs, Humans, Immunization Schedule, Influenza Vaccines, Influenza, Human, Models, Economic, Quality-Adjusted Life Years
Abstract

While studies have found influenza vaccination to be cost-effective in older adults (65 years or older), they have not looked at how the vaccine's economic value may vary with the timing of vaccine administration. We developed a set of computer simulation models to evaluate the economic impact of vaccinating older adults at different months. Our models delineated the costs and utility losses in delaying vaccination past October and suggest that policy makers and payors may consider structuring incentives (< or =$2.50 per patient) to vaccinate in October. Our results also suggest that vaccination is still cost-effective through the end of February.

DOI10.1016/j.vaccine.2009.09.056
Alternate JournalVaccine
PubMed ID19786135
PubMed Central IDPMC2783217
Grant ListU01 GM070708 / GM / NIGMS NIH HHS / United States
U01 GM070708-05 / GM / NIGMS NIH HHS / United States
U01-GM070708-05 / GM / NIGMS NIH HHS / United States
U54 GM088491 / GM / NIGMS NIH HHS / United States
Publication Categories: